logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Jason M. Pogue

university of michigan

52H指数
265论文数
1.0W被引数
收录论文 124
发表时间
logo
Gram-negative bacterial infection randomized controlled trials (RCTs) in the 21st century: characteristics and evolution21世纪革兰氏阴性菌感染随机对照试验（RCT）的特征与演变
errJAC-Antimicrobial Resistance
IF3.3
err2026-07-23
err0
errOAAI
errFabian Patauner; Hyeri Seok; Navaneeth Narayanan; Jason M Pogue; Emanuele Durante-Mangoni; Keith S Kaye
err分享
err收藏
Early Symptom Response in Patients With Uncomplicated Urinary Tract Infection Treated With Gepotidacin or Nitrofurantoin: Pooled Analysis From Two Pivotal Phase 3 Studies未并发尿路感染患者使用Gepotidacin或Nitrofurantoin治疗后的早期症状反应：两项关键III期研究的合并分析
errClinical Infectious Diseases
IF7.3
err2026-02-01
err0
errOAAI
errSheets, Amanda J.; Dennison, Jeremy; Pogue, Jason M.; Kaye, Keith S.; Perry, Caroline; Millns, Helen; Diaz-Reganon, Jazmin; Janmohamed, Salim
err分享
err收藏
First Report of Treatment-Emergent Resistance to Cefepime-Zidebactam in Pseudomonas aeruginosa首次报道铜绿假单胞菌对头孢吡肟-西地那非他胺治疗中出现耐药性
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2025-12-01
err1
PREAI
errDorazio, Ava J.; Aitken, Samuel L.; Pierce, Virginia M.; Kline, Ellen G.; Squires, Kevin M.; Pogue, Jason M.; Shields, Ryan K.
err分享
err收藏
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and Pseudomonas aeruginosa基于肾功能调整和体外敏感性试验解释标准的肠杆菌科细菌及铜绿假单胞菌氨基糖苷类药物给药方案评价
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2025-12-01
err0
PREAI
errBhavnani, Sujata M.; Hammel, Jeffrey P.; Onufrak, Nikolas J.; Pogue, Jason M.; Jones, Ronald N.; Sader, Helio S.; Drusano, George L.; Bradley, John S.; Andes, David R.; Craig, William A.; Ambrose, Paul G.
err分享
err收藏
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and Pseudomonas aeruginosa: Brief Summary评价基于肾功能调整的氨基糖苷类药物给药方案及体外药敏试验解释标准对肠杆菌科细菌和铜绿假单胞菌的应用：简要总结
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2025-12-01
err0
errOAAI
errBhavnani, Sujata M.; Hammel, Jeffrey P.; Onufrak, Nikolas J.; Pogue, Jason M.; Jones, Ronald N.; Sader, Helio S.; Drusano, George L.; Bradley, John S.; Andes, David R.; Craig, William A.; Ambrose, Paul G.
err分享
err收藏
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of People With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens协同疗法（Colistin和Meropenem联合）对由碳青霉烯耐药革兰氏阴性病原体引起的肺炎或血流感染患者结局的影响
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2025-11-01
err1
PREAI
errHuralska, Mariya; Pogue, Jason M.; Rybak, Michael; Abdul-Mutakabbir, Jacinda C.; Stamper, Kyle; Marchaim, Dror; Thamlikitkul, Visanu; Carmeli, Yehuda; Chiu, Cheng-Hsun; Daikos, George; Dhar, Sorabh; Durante-Mangoni, Emanuele; Gikas, Achilles; Kotanidou, Anastasia; Paul, Mical; Roilides, Emmanuel; Samarkos, Michael; Sims, Matthew; Tancheva, Dora; Tsiodras, Sotirios; Kett, Daniel H.; Patel, Gopi; Calfee, David P.; Leibovici, Leonard; Power, Laura; Munoz-Price, Silvia; Shaikh, Hamadullah; Susick, Laura; Latack, Katie; Chiou, Christine; Divine, George; Ghazyaran, Varduhi; Kaye, Keith S.
err分享
err收藏
Actually, It May be Time to Return to Colistin and Meropenem in Some Patients Infected With Carbapenem-resistant A. baumannii (CRAB)实际上，对于某些感染了耐碳青霉烯鲍曼不动杆菌（CRAB）的患者，可能到了重新使用多粘菌素和美罗培南的时候。
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2025-10-01
err0
PREAI
errPogue, Jason M.; Kaye, Keith S.
err分享
err收藏
How do I manage Difficult-to-Treat Pseudomonas aeruginosa infections?: Key Questions for Today’s Clinicians如何管理难治性铜绿假单胞菌感染？：当今临床医生的关键问题
errClinical Microbiology and Infection
IF8.5
err2025-08-23
err0
PREAI
errJuan P. Horcajada; Ana Gales; Burcu Isler; Keith S. Kaye; Andrea L. Kwa; Cornelia B. Landersdorfer; Maria Milagro Montero; Antonio Oliver; Jason M. Pogue; Ryan K. Shields; Maria Virginia Villegas; Dafna Yahav; David L. Paterson
err分享
err收藏
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity鲍莫西B在危重患者中的群体药代动力学/毒效动力学模型，以识别肾毒性风险
errClinical Pharmacology & Therapeutics
IF5.5
err2025-06-16
err0
errOAAI
errPatrick O. Hanafin; Ramya Mahadevan; Gauri G. Rao; Alexandre P. Zavascki; Ana Maria Sandri; Andrea Kwa; Marc H. Scheetz; Christine J. Kubin; Jayesh Shah; Benjamin P.Z. Cherng; Michael T. Yin; Jiping Wang; Lu Wang; David P. Calfee; Maureen Bolon; Anthony W. Purcell; Roger L. Nation; Jason M. Pogue; Jian Li; Keith S. Kaye
err分享
err收藏
The Antibiotic Pipeline Has Delivered for Drug-Resistant Gram-Negative Pathogens, Now Global Access Must Follow抗生素研发管线已为耐药革兰氏阴性病原体带来突破，如今全球可及性必须紧随其后。
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2025-06-01
err0
PREAI
errPogue, Jason M.; van Duin, David
err分享
err收藏
Restoring ceftolozane susceptibility: a role for diazabicyclooctane β-lactamase inhibitors?
errANTIMICROBIAL AGENTS AND CHEMOTHERAPY
IF4.5
err2025-01-28
err0
errOAAI
errDorazio, Ava J.; Kline, Ellen G.; Squires, Kevin M.; Pogue, Jason M.; Van Tyne, Daria; Shields, Ryan K.
err分享
err收藏
A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk Factors
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2024-10-30
err1
errOAAI
errWangchinda, Walaiporn; Aitken, Samuel L.; Klatt, Megan E.; Lephart, Paul R.; Smith, Aaron B.; Pogue, Jason M.
err分享
err收藏
Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia接受多重耐药铜绿假单胞菌菌血症或肺炎治疗的患者对头孢他啶-阿维巴坦和头孢特咯瓒-他唑巴坦的耐药率
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2024-06-21
err6
errOAAI
errShah, Sunish; Kline, Ellen G.; Haidar, Ghady; Squires, Kevin M.; Pogue, Jason M.; Mccreary, Erin K.; Ludwig, Justin; Clarke, Lloyd G.; Stellfox, Madison; Van Tyne, Daria; Shields, Ryan K.
err分享
err收藏
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing肠杆菌的哌拉西林/他唑巴坦药敏试验解释标准: 美国抗菌药物敏感性试验委员会的建议
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2024-06-21
err1
errOAAI
errLodise, Thomas P.; Bhavnani, Sujata M.; Ambrose, Paul G.; Sader, Helio S.; Andes, David; Pogue, Jason M.
err分享
err收藏
Is it time to join the oral antibiotics bandwagon?
errLANCET INFECTIOUS DISEASES
IF31
err2024-05-01
err0
PREAI
errJusto, Julie Ann; Pogue, Jason M.
err分享
err收藏
The Growing Threat of NDM-Producing E. Coli With Penicillin-Binding Potein 3 Mutations in the United States-Is There a Potential Role for Durlobactam?
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2024-04-25
err4
PREAI
errAitken, Samuel L.; Pierce, Virginia M.; Pogue, Jason M.; Kline, Ellen G.; Tverdek, Frank P.; Shields, Ryan K.
err分享
err收藏
Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections
errJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
IF3.6
err2024-04-10
err3
PREAI
errWangchinda, Walaiporn; Pogue, Jason M.; Thamlikitkul, Visanu; Leelawattanachai, Pannee; Koomanachai, Pornpan; Pai, Manjunath P.
err分享
err收藏
A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa
errJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
IF3.6
err2024-04-06
err0
PREAI
errWangchinda, Walaiporn; Kaye, Keith S.; Patel, Twisha S.; Albin, Owen R.; Saravolatz II, Louis; Petrie, Joshua G.; Pogue, Jason M.
err分享
err收藏
Tebipenem and Sulopenem: Dynamic Duo or Double Trouble?
errinfectious disease reports
IF2.9
err2024-02-10
err2
errOAAI
errMangum, Blake R.; Pogue, Jason M.; Barber, Katie E.
err分享
err收藏
Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosa
errCLINICAL MICROBIOLOGY AND INFECTION
IF8.5
err2024-02-01
err2
PREAI
errAlbin, Owen R.; Pogue, Jason M.; Wunderink, Richard G.; Kaye, Keith S.
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
D
David L. Paterson
H 指数: 131 · 论文数: 950
M
Marin H. Kollef
H 指数: 128 · 论文数: 906
R
Ronald N. Jones
H 指数: 127 · 论文数: 1.6K
R
Robert A. Bonomo
H 指数: 115 · 论文数: 1.1K
D
David R. Andes
H 指数: 110 · 论文数: 596
查看更多